NEW YORK, June 26 - MediChem Life Sciences has agreed to a two-year deal to crystallize and determine three-dimensional protein structures for Neurocrine Biosciences, the companies said Tuesday.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: global genetic diversity map, and more.
The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.
In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."
Stat News reports that there's muted opposition to the Kuwaiti DNA database law.